Ignite Creation Date:
2025-12-24 @ 3:45 PM
Ignite Modification Date:
2026-05-28 @ 5:57 AM
Study NCT ID:
NCT01962792
Status:
COMPLETED
Last Update Posted:
2021-12-21
First Post:
2013-09-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of BTK Inhibitor, Ibrutinib in Combination With Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma
Sponsor:
Pharmacyclics LLC.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Myeloma | View |